Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort Study
NCT ID: NCT07249138
Last Updated: 2025-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2025-02-15
2025-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Integrated Study in Pediatric Patients with Cardiomyopathy
NCT06641830
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
NCT04604418
Quality of Life Among Children With Congenital Heart Disease
NCT01202916
Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years
NCT04812210
Construction of a Multi-center Clinical Research Collaboration Network for Children with Congenital Heart Disease in China
NCT06885307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort of pediatric patients with congenital heart disease and hematological tumors
No interventions assigned to this group
Cohort of pediatric patients with hematological tumors
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged 0-17 years at diagnosis, regardless of gender;
3. Completed standard treatment for hematologic malignancies and confirmed diagnosis of congenital heart disease by cardiac ultrasound and clinical evaluation;
4. Written informed consent can be provided by the child or their legal guardian.
Exclusion Criteria
2. Other serious cardiac conditions, malignancies, or comorbidities that may interfere with study results;
3. Inability to provide the information and data required for the study.
0 Weeks
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Children's Hospital
OTHER
Children's Hospital of Suzhou University
UNKNOWN
Tongji Hospital
OTHER
Shandong Provincial Hospital
OTHER_GOV
Guangzhou Women and Children's Medical Center
OTHER
Wuhan Children's Hospital
OTHER
Union Hospital of Huazhong University of Science and Technology
UNKNOWN
The Third Xiangya Hospital of Central South University
OTHER
Inner Mongolia Maternal and Child Health Care Hospital
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Beijing Children's Hospital
OTHER
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
OTHER
Shanxi Provincial Maternity and Children's Hospital
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Shanghai Children's Hospital
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Hebei Medical University Fourth Hospital
OTHER
Children's Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Children's Hospital
Beijing, , China
The Third Xiangya Hospital of Central South University
Changsha, , China
Guangzhou Women and Children's Medical Center
Guangzhou, , China
Inner Mongolia Maternal and Child Health Care Hospital
Hohhot, , China
Shandong Provincial Hospital
Jinan, , China
Nanjing Children's Hospital
Nanjing, , China
The First Affiliated Hospital of Guangxi Medical University
Nanning, , China
The Affiliated Hospital of Qingdao University
Qingdao, , China
Children's Hospital of Fudan University
Shanghai, , China
Shanghai Children's HospitalShanghai Children's Hospital
Shanghai, , China
The Fourth Hospital of Hebei Medical University
Shijiazhuang, , China
Children's Hospital of Soochow University
Suzhou, , China
Shanxi Children's Hospital
Taiyuan, , China
Tongji Hospital of Huazhong University of Science and Technology
Wuhan, , China
Union Hospital of Huazhong University of Science and Technology
Wuhan, , China
Wuhan Children's Hospital
Wuhan, , China
Northwest Women's and Children's Hospital
Xi'an, , China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHOPA0012-CHFUCHD-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.